Dear Doctor: We Really Are Not Sure What Dose of Capecitabine You Should Prescribe for Your Patient

This publication has 8 references indexed in Scilit:

• Body Surface Area as a Determinant of Pharmacokinetics and Drug Dosing
  Investigational New Drugs, 2001
• 5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer
  British Journal of Cancer, 2001
• Gazing into a crystal ball–cancer therapy in the post-genomic era
  Nature Medicine, 2001
• Estimation of glomerular filtration rate in cancer patients
  British Journal of Cancer, 2001
• Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients
  Cancer Chemotherapy and Pharmacology, 1999
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
  Annals of Internal Medicine, 1999
• Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?
  Journal of Clinical Oncology, 1998
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue
  Published by Elsevier ,1998